muramidase and Cat-Diseases

Activity of fecal lysozyme was determined in healthy cats and cats with chronic diarrhea. The established reference value ranged from 0 up to 2.6 micrograms/g feces. Mean activity of the control group was 1.3 +/- 0.9 micrograms/g feces, mean activity of the patient group was 3.4 +/- 3.3 micrograms/g. There was a statistically significant difference between these two values. Nevertheless it was not possible to classify various diseases by evaluating lysozyme activity. In addition to endoscopy and histological examination, determination of lysozyme can be used as screening test and means of assessment for treatment and progress in cats with chronic diarrhea.

Topics: Animals; Cat Diseases; Cats; Chronic Disease; Diarrhea; Feces; Muramidase; Reference Values

Topics: Animals; Cat Diseases; Cats; Female; Histiocytic Sarcoma; Immunoenzyme Techniques; Muramidase

Topics: alpha 1-Antitrypsin; Animals; Cat Diseases; Cats; Colonic Neoplasms; Female; Immunoenzyme Techniques; Muramidase; Sarcoma

This study investigated the potential for nephrotoxicity of gentamicin in cats by measuring marker enzyme concentrations, [Na], [K], osmolality, and pH of the urine, and blood urea nitrogen (BUN) levels. Gentamicin was administered i.m. at 4.4 mg/kg once daily (s.i.d.) or twice daily (b.i.d.) for 7 days. Concentrations of lactic dehydrogenase (LDH), lysozyme (LZM), alkaline phosphatase (AP), and glutamate dehydrogenase (GD) were measured as total 24-h excretions. The s.i.d. regimen produced only a slight increase in LDH excretion after 5 days, whereas the b.i.d. regimen caused an increase in the excretion of all enzymes. The greatest elevations were observed for LZM and LDH. Of the enzymes studied, these appeared to be the most appropriate to monitor for potential nephrotoxicity, except that urinary concentrations did not correlate well with duration of gentamicin administration. Only slight elevations in BUN were observed for either regimen. Single daily administration increased urine osmolality slightly, but b.i.d. treatment caused a marked and immediate decrease in urine osmolality, [Na], and total Na excretion. Urinary [K] was also depressed, as was total K excretion after 6 days. Urine pH was not substantially affected. This study showed that the recommended daily dose of 4.4 mg/kg produced little if any evidence of nephrotoxicity as indicated by the parameters measured. Twice daily dosing, however, produced elevations in urine enzyme concentrations, and markedly decreased urine osmolality and Na and K excretion. Compared to other species studied, the cat appears particularly sensitive to urine concentrating alterations resulting from repeated gentamicin administration.

Topics: Alkaline Phosphatase; Animals; Blood Urea Nitrogen; Cat Diseases; Cats; Electrolytes; Female; Gentamicins; Glutamate Dehydrogenase; Kidney; Kidney Concentrating Ability; L-Lactate Dehydrogenase; Male; Muramidase

Comparative studies of the lysozyme test (LT) and the Schirmer tear test (STT) revealed that the LT was not reliable in the diagnosis of kerato-conjunctivitis sicca (KCS) in dogs and cats. This is in contrast to its successful use in human patients. No M. lysodeikticus lysating substrates were detectable in the tear fluid of the normal cat.

Topics: Animals; Cat Diseases; Cats; Dog Diseases; Dogs; Keratoconjunctivitis; Micrococcus; Muramidase; Tears